Home›People›Ryan Jones
RJ

Ryan Jones

Chief Financial Officer at Kyverna Therapeutics.

ExecutivePublic company
Updated Nov 2, 2026·Latest SEC filing Apr 15, 2025·Suggest an edit

About Ryan Jones

Ryan Jones is a chief financial officer at Kyverna Therapeutics.

Ryan Jones reports to the SEC as an officer of 1 public company.

Ryan Jones first appears on SEC filings in 2023.

Experience

This experience comes from SEC filings. The years are when the filings name Ryan Jones in the role, so the role may have started earlier or lasted longer.

Kyverna Therapeutics, Inc.
Chief Financial Officer
2023 – 2025 · Public company (KYTX)

Key Colleagues at Startups

The people Ryan Jones works with at each company, as listed on that company's latest Form D.

Kyverna Therapeutics, Inc. · Form D, Nov 7, 2023
BK
Brian Kotzin
Director
IC
Ian Clark
Director
KW
Karen Walker
Executive officer
PM
Peter Maag
Executive officer and director
JC
James Chung
Executive officer
DS
BS
FC
Fred Cohen
Director
SL
Steve Liapis
Director
DB
Dominic Borie
Executive officer

Sources

  1. SECKyverna Therapeutics, Inc. Form D, filed Nov 7, 2023
  2. SECForms 3, 4 and 5 filed by Ryan Jones (SEC filer 2007219)